Genomic and Molecular Markers in Glioma: Where Are We Now?

Описание: Presented by: Dr. Mary Jane Lim-Fat, Neuro-Oncologist at Sunnybrook Health Sciences Centre

This presentation reviews the current use of molecular and genomic markers in glioma in clinical care and some of the potential benefits and current limitations. We also discuss how these markers are impacting management decisions for specific groups of patients with gliomas, in particular young adult diagnosed with a glioma.


- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Connect with Brain Tumour Foundation of Canada:
Facebook:   / braintumourf...​  
Facebook francophone:   / fondationcan​​​.  .
Twitter:   / braintumourfdn​​​  
Instagram:   / braintumour...​  
Pinterest:   / braintumour...​  

Call Toll Free 1-800-265-5106 or locally 519-642-7755 - call with any questions and connect today!

Brain Tumour Foundation of Canada
205 Horton St E, Suite 203,
London, ON N6B 1K7

http://www.BrainTumour.ca​​​

Charitable Registration #BN118816339RR0001​​​

Copyright and Terms of Use Statement - Videos
Copyright of all videos created by Brain Tumour Foundation of Canada on this website, including the underlying HTML, text, illustrations, designs, icons, audio clips, video clips, documents, products, software and all other content is either owned by the Brain Tumour Foundation of Canada, or Brain Tumour Foundation of Canada has obtained a license to use the materials.

The videos on the site are protected by the Copyright Act. None of the videos may be copied, reproduced, distributed, republished, downloaded, or transmitted in any form or by any means, without the prior written consent of Brain Tumour Foundation of Canada, or the original creator, where applicable.

All information within the videos has been posted to provide Canadians affected by a brain tumour with support, education, information and an understanding of research programs or to thank donors and supporters for their contributions. The information has been posted with the intent that it be readily available for personal and public non-commercial (educational) use. The allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.